SU533323A3 - Способ усилени биологической активности -окситриптофана - Google Patents

Способ усилени биологической активности -окситриптофана

Info

Publication number
SU533323A3
SU533323A3 SU1940152A SU1940152A SU533323A3 SU 533323 A3 SU533323 A3 SU 533323A3 SU 1940152 A SU1940152 A SU 1940152A SU 1940152 A SU1940152 A SU 1940152A SU 533323 A3 SU533323 A3 SU 533323A3
Authority
SU
USSR - Soviet Union
Prior art keywords
hydroxytryptophan
hydrazine
trioxybenzyl
seryl
biological activity
Prior art date
Application number
SU1940152A
Other languages
English (en)
Russian (ru)
Inventor
Хефели Вилли
Original Assignee
Ф.Хоффманн Ля Рош И Ко Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн Ля Рош И Ко Аг (Фирма) filed Critical Ф.Хоффманн Ля Рош И Ко Аг (Фирма)
Application granted granted Critical
Publication of SU533323A3 publication Critical patent/SU533323A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU1940152A 1972-06-30 1973-06-28 Способ усилени биологической активности -окситриптофана SU533323A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH984672 1972-06-30

Publications (1)

Publication Number Publication Date
SU533323A3 true SU533323A3 (ru) 1976-10-25

Family

ID=4356299

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1940152A SU533323A3 (ru) 1972-06-30 1973-06-28 Способ усилени биологической активности -окситриптофана

Country Status (18)

Country Link
AT (1) AT338412B (xx)
AU (1) AU476456B2 (xx)
BE (1) BE801645A (xx)
CA (1) CA1015272A (xx)
DD (1) DD107592A5 (xx)
DE (1) DE2327636A1 (xx)
ES (1) ES416383A1 (xx)
FR (1) FR2190453B1 (xx)
GB (1) GB1369189A (xx)
HU (1) HU167292B (xx)
IE (1) IE37833B1 (xx)
IL (1) IL42317A (xx)
LU (1) LU67898A1 (xx)
NL (1) NL7308435A (xx)
PH (1) PH9584A (xx)
SE (1) SE407744B (xx)
SU (1) SU533323A3 (xx)
ZA (1) ZA733284B (xx)

Also Published As

Publication number Publication date
IE37833B1 (en) 1977-10-26
IL42317A (en) 1976-04-30
FR2190453A1 (xx) 1974-02-01
PH9584A (en) 1976-01-19
NL7308435A (xx) 1974-01-02
ES416383A1 (es) 1976-02-16
IL42317A0 (en) 1973-07-30
AT338412B (de) 1977-08-25
IE37833L (en) 1973-12-30
GB1369189A (en) 1974-10-02
LU67898A1 (xx) 1975-04-11
BE801645A (fr) 1974-01-02
HU167292B (xx) 1975-09-27
AU476456B2 (en) 1976-09-23
DD107592A5 (xx) 1974-08-12
CA1015272A (en) 1977-08-09
FR2190453B1 (xx) 1976-04-09
ATA574273A (de) 1976-12-15
SE407744B (sv) 1979-04-23
AU5589773A (en) 1974-11-21
DE2327636A1 (de) 1974-01-17
ZA733284B (en) 1974-03-27

Similar Documents

Publication Publication Date Title
US2892753A (en) Central nervous system stimulant
EA015382B1 (ru) Применение рофлумиласта для лечения сахарного диабета типа 2
JPS6313967B2 (xx)
KR20020060192A (ko) Nk₁ 수용체 길항제와 gaba 구조유사체의 상승적배합물
JPS5938203B2 (ja) 補酵素qを主成分とする脳循環障害治療剤
SU533323A3 (ru) Способ усилени биологической активности -окситриптофана
NO784357L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO822385L (no) Terapeutisk preparat.
RU2283114C1 (ru) Композиция, обладающая гепатопротекторной активностью и нормализующая обменные процессы
RU2725622C1 (ru) Фармацевтическая композиция для лечения и/или профилактики заболеваний печени
US3896232A (en) Substituted benzylidene hydrazines as anti-migraine syndrome agents
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
RU92004569A (ru) Фармацевтический препарат антистрессорного, стресспротекторного и ноотропного действия
RU2084225C1 (ru) Гипотензивное средство
US3932652A (en) Antidepressant compositions
US3360434A (en) Method for reducing blood pressure with phenylalanine derivatives
IE71022B1 (en) Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamides containing preparation and stabilizing method therefor
DE69301360T2 (de) Neuroprotektivum
Borysiewicz et al. Scombrotoxic atrial flutter.
RU2225713C1 (ru) Фармацевтическая композиция, обладающая антиангинальным, антиишемическим и ноотропным действием
RU2341254C1 (ru) Стабильная фармацевтическая композиция, обладающая антигипертензивным действием
RU2019184C1 (ru) Способ получения биологически активного средства на основе березового сока
US10647745B2 (en) Compound for treating sequelae of ischemic cerebral stroke
KR970006083B1 (ko) 위장질환 치료용 의약 조성물
US4218466A (en) Method of treating gastric and duodenal ulcers